Spotlight -

Downstream Processing|

Upstream Processing

Greg Swan

Greg Swan is business development manager, cell & gene therapies, at Avantor.

Articles by Greg Swan

Adeno-associated virus. AAV virus genome. Adenoviral pneumonia, arthritis, bronchitis, hepatitis, cystitis. Adenovirus as vectors for gene therapy. Genetic material transmission to cell. Biotech 3D | Image Credit: © Corona Borealis - © Corona Borealis - stock.adobe.com

Improving Vector Yield at Scale: A Fresh Approach to Cell Lysis Quality Assessment

ByGreg Swan,Beth Kroeger-Fahnestock

December 26th 2024

Optimizing the harvest of viral particles is important for the yield and purity of the final product.

Latest Updated Articles

Trending on BioPharm International

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

© 2025 MJH Life Sciences^®

All rights reserved.